Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-13-011365
Filing Date
2013-07-02
Accepted
2013-07-02 19:16:42
Documents
2
Period of Report
2013-06-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3848
2 ex24fust.txt EX-24 3121
  Complete submission text file 0001179110-13-011365.txt   8448
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1034 NOE STREET SAN FRANCISCO CA 94114
Business Address
Fust Matthew (Reporting) CIK: 0001339226 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 13950477